30 closest matches · ranked by relevance
Healthy Subject
Primary: Feasibility and Retention for a Trial With Daily Doses of 35 g of Fiber and 6.2 g of EPA +DHA (and Corresponding Comparators) — 14; 15; 1; 1 Participants
Colorectal Cancer
Primary: FIT Completion — 10.4; 13.9 Model based percentage of participants — p=.05
Cancer Screening Tests
Primary: Number of Participants Who Completed Colorectal Cancer Screening — 110; 95; 113; 113 Participants
Colon Cancer · Precancerous Condition · Rectal Cancer
Primary: Change of a Spectral Biomarker for Colonic Carcinogenesis (Called Spectral Slope or SPEC) From Baseline to 3 Months. — 40.72; 37.54; 43.45; 37.52 micron^-1 — p=0.11
Colon Cancer
Primary: Adherence to Dietary Goals — 89; 85 percentage of participants meeting goals
Colorectal Cancer
Primary: Percent of Patients Receiving GI Consult for FOBT+ Results — 39; 47; 64; 51 percent patients receiving GI consult
Colorectal Cancer · Screening
Primary: Colorectal Cancer Stage (pTNM) — 46; 85 Participants
Colorectal Cancer
Primary: Concordance Between Patient Preference and Test Ordered — 148; 147 Participants — p=0.40
Colorectal Cancer
Primary: Colorectal Cancer Screening Participation, Defined as Completion of a Guaiac or Immunochemical Stool Occult Blood Test, Colonoscopy, Sigmoidoscopy, or Barium Enem…
Colorectal Cancer
Primary: TRPM7 Expression Level in Colorectal Mucosa by Mg Treatment Compared With Placebo — 0.03; 0.08; -0.09; -0.11 log (arbitrary units) — p=>0.05
Colorectal Cancer Screening
Primary: Facilitators and Barriers to Implementing Decision Aids, Provider Notifications, and Personal Risk Calculation Using an Electronic Health Record (EHR) to Promote…
Colorectal Neoplasms
Primary: Completion of a Fecal Occult Blood Test (FOBT) — 185; 84 participants
Colorectal Adenomatous Polyps
Primary: Rectal Epithelial Cell Proliferation — 19.3; 20.3; 18.9; 16.8 percentage of cells positive
Adenomatous Polyp · Colorectal Cancer · Obesity
Primary: Change in Activated S6serine235 (i.e., the Ratio of pS6serine235/S6serine235) — 0.0228 weighted ratio of staining cells — p=> 0.773
Adenomatous Polyp · Colorectal Carcinoma
Primary: Difference (After Treatment Minus Before Treatment) of EGFR Expression — 0.17; -0.40; 0.21 ng/ml
Colorectal Neoplasms
Primary: Colorectal Cancer Screening — 127; 112 participants — p=0.01
Colorectal Cancer
Primary: Rectal Tissue Putrescine Reduction — 17 Participants
Colorectal Cancer · Polyps · Adenomas
Primary: Colorectal Adenomas — 48.2; 44.9; 47.0; 45.7 percentage of subjects
Colorectal Cancer
Primary: Number of Participants Who Completed Colorectal Cancer Screening — 11; 16; 18; 19 Participants
Colorectal Cancer
Primary: Change in Knowledge Related to Colorectal Cancer Risk, Prevention, and Screening — 1 score on a scale — p=0.0001
Colorectal Neoplasms · Digestive System Diseases · Colonic Diseases
Primary: Sensitivity and Specificity of the Exact CRC Screening Test With Comparison to Colonoscopy, Both With Respect to Cancer. — 92.3; 73.8; 93.3; 73.3 percent
Colorectal Cancer
Primary: FIT Completion Among Patients Offered Any Incentive vs. Outreach Alone Each Year — 2391; 738; 1255; 394 Participants — p=0.59
Colonic Cancer
Primary: Number of Participants in Determining Messages — 1051; 1135; 0 Participants
Colonic Neoplasms · Colorectal Neoplasms · Colonic Diseases
Primary: Intentions to Get Screened for Colon Cancer — 68.64; 65.51; 64.30 units on a 0-100 scale — p=.362
Colorectal Cancer
Primary: Use of FOBT ColoCARE Home Kit — 14; 2; 14; 0 participants
Colon Polyps
Primary: Number of Participants With Delayed Bleeding Complications — 16; 33 Participants
Colorectal Cancer Screening
Primary: Colorectal Cancer (CRC) Screening Completion — 99; 99 Participants
Colorectal Cancer
Primary: Number of Participants With CRC Screening Ordered — 162; 114 Participants — p=0.491
Adenomatous Polyps
Primary: Percent of Incompletely Resected Adenomatous Polyps — 10.1 percentage of incomplete resection
Colorectal Cancer
Primary: Number of Patients With Provider Referral for Risk-appropriate Colorectal Cancer Screening — 219; 232 Participants — p=0.16